This animation laid the foundation disease awareness story for the first new migraine drug in decades: Aimovig (erenumab). It begins with the burden of disease of migraine, moves through pathophysiology, then dives into the story of a key molecular player: CGRP. A thorough review of the migraine literature informed the script and visuals. All models and anatomy are data-driven.
Keywords: Animation, 3D, Anatomy, Molecular Biology, Neuroscience, Pharmacology, Mechanism of Action (MOA), Pathology